|
Assisted Outpatient Treatment for Individuals with Serious Mental Illness
|
Research Initiative
|
SAMHSA, ASPE
|
NIMH
|
This collaboration supported the development and implementation of a rigorous and objective cross-site impact evaluation of an Assisted Outpatient Treatment Grant Program for Individuals with Serious Mental Illness. The Department of Health and Human Services, Assistant Secretary for Planning and Evaluation (ASPE) had primary responsibility for the solicitation, management, and implementation of the evaluation contract in consultation with the Substance Abuse and Mental Health Services Administration (SAMHSA) and the National Institute of Mental Health (NIMH). The Center for Behavioral Health Statistics and Quality (CBHSQ), an entity within SAMHSA that serves as a focal point for data collection, analysis, and the dissemination of critical public health data, provides consultation on the cross-site evaluation of the Assisted Outpatient Treatment grant program. ASPE, in consultation with the NIMH, brings expertise in evaluation design and implementation that benefits SAMHSA in its priority of having a rigorous multi-site evaluation. The initial Phase I Implementation Evaluation was completed in FY 2017. Results of the Implementation Evaluation were used to inform the design and data collection plan for the Phase II Outcome Evaluation, which began in FY 2019. Activities in FY21 included data analysis and preparation and review of the evaluation report for dissemination.
|
|
Autoimmune Diseases Coordinating Committee
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA, HRSA
|
NIAID, CSR, FIC, NCATS, NCCIH, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NINDS, NINR
|
The purpose of the Autoimmune Diseases Coordinating Committee (ADCC) is to provide a forum for the coordination of research efforts in autoimmunity and autoimmune diseases among various stakeholders including the National Institutes of Health (NIH), other federal agencies such as the Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC), and private organizations with an interest in autoimmune diseases. The ADCC meets twice yearly to discuss a broad range of basic, preclinical, and clinical endeavors.
|
|
Behavioral Health Coordinating Council (BHCC) Children and Youth Behavioral Health Subcommittee
|
Committee, Work group, Advisory group, or Task Force
|
ACF, CMS, ACL, AHRQ, FDA, IHS, ASPE, CDC, OASH
|
NICHD, NIMH, NIDA
|
The HHS Behavioral Health Coordinating Council (BHCC) Children and Youth Subcommittee addresses these high-level priorities/areas of focus for children and youth: Ensure children, youth, and caregivers have access to appropriate behavioral health prevention resources, screening, referral, and treatments in their communities, schools, and early education settings; Address behavioral health needs resulting from the COVID-19 pandemic; Advance health equity by addressing the health needs of underserved communities; Support the behavioral health workforce that serves children and youth.
|
|
Behavioral Health Coordinating Council (BHCC) Performance Measures, Data, and Evaluation Subcommittee (MDE)
|
Committee, Work group, Advisory group, or Task Force
|
ACF, ACL, AHRQ, ASA, ASPE, CDC, CMS, FDA, IHS, NIH, ONC, SAMHSA
|
NIDA, NIMH
|
The goal of the Behavioral Health Coordinating Council (BHCC) Performance Measures, Data, and Evaluation Subcommittee (MDE) working group is to ensure that HHS leadership has the data and analyses needed to ensure that behavioral health is incorporated into HHS efforts. The working group will identify data gaps and propose ways to address them.
|
|
Bench to Bedside: Integrating Sex and Gender to Improve Human Health
|
Resource Development
|
FDA
|
OD/DPCPSI/ORWH
|
Bench to Bedside: Integrating Sex and Gender to Improve Human Health was developed in partnership with the Food and Drug Administration (FDA) Office of Women’s Health (OWH). This online course gives users a thorough and up-to-date understanding of sex and gender influences on health and disease so users can apply this knowledge when conducting research and interpreting evidence for clinical practice. Course material showcases examples from basic science through clinical trials and translation into practice to ensure participants understand the importance of considering the influence of sex and gender throughout the research spectrum and beyond. Through its six modules, the course focuses on key health conditions on which sex and gender have an impact. The six modules that compose the course are Immunology, Cardiovascular disease, Pulmonary disease, Neurology, Endocrinology, and Mental Health.
|
|
Best Pharmaceuticals for Children Act (BPCA) Data Monitoring Committee
|
Committee, Work group, Advisory group, or Task Force
|
FDA
|
NICHD, NCI, NHLBI
|
This group provides safety oversight for all studies conducted under BPCA.
|
|
Best Pharmaceuticals for Children Act (BPCA) Research Oversight Committee
|
Committee, Work group, Advisory group, or Task Force
|
FDA
|
NICHD, NHLBI, NCI
|
This group provides programmatic support to project lead for the BPCA clinical program which includes the oversight prioritization and concept developments for the Pediatric Trials Network.
|
|
Biodefense Coordination Team (BCT)
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA, OS
|
OD/OSP
|
Coordinates implementation of the U.S. National Biodefense Strategy and Presidential Memorandum on the Support for Biodefense towards an integrated, comprehensive approach to manage biodefense activities in support of the broader biodefense enterprise.
|
|
Biodosimetry Trans-NIH Working Group and Special Journal Issue
|
Committee, Work group, Advisory group, or Task Force
|
ASPR, FDA
|
NIAID
|
This collaboration highlights regulatory and scientific approaches in research and advancement of biodosimetry tests in both NIAID and BARDA portfolios
|
|
Biomarkers of Exposure and Effect in Agriculture (BEEA)
|
Research Initiative
|
CDC
|
NCI
|
National Cancer Institute (NCI) and the Centers for Disease Control and Prevention (CDC) are collaborating to characterize exposure to permethrin and other pesticides by measuring urinary metabolites among participants in the Biomarkers of Exposure and Effect in Agriculture (BEEA) study.
|